Genetic Rx panel on gene therapy regulatory strategies led by Renova Therapeutics CEO and Co-founder – PR Newswire (press release)
|
Genetic Rx panel on gene therapy regulatory strategies led by Renova Therapeutics CEO and Co-founder
PR Newswire (press release) The company's lead product candidate, RT-100, is a treatment that delivers a therapeutic gene directly to the heart during a routine outpatient procedure and has the potential to increase heart function in millions of patients with heart failure. The … |
